Stock Ratings / Health Care / MD / insiders

BKD (46) SGRY (66) ARDT (67) NHC (69) ⌘ Pro Terminal →

Pediatrix Medical Group Inc. (MD) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$29.18 +0.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Pediatrix Medical Group Inc. (MD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (steady margins, 34% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $2.37B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MD)Realized 20D OHLCV Swing Band: ±6.7%

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

MD Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (MD)

No recent open-market Form 4 cluster sales or emergency dumps flagged on MD. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (MD Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +29.63%▲ ASCENDING CHANNEL

2026-10-30O $29.48H $29.97L $29.07C $29.18VOL 1.11M

RES: $30.35SUP: $25.55SMA50: $26.93SMA200: $23.87

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MD Butterfly Map → + Track MD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

6.2%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MD)

Health Care Rank #53 of 1016 ⚔️ BKD vs MD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MD vs. BKD, SGRY, ARDT, NHC)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Pediatrix Medical Group Inc. (MD) ranks #53 by composite RQD confidence (74/100, grade B) and #228 by equity capitalization ($2.37B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently leads its immediate peer cohort in composite quantitative strength at 74/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MD ACTIVE Pediatrix Medical Group Inc.	B	74/100	14.3x	—	33.6%	+0.93%	$2.37B	Benchmark Subject
BKD Brookdale Senior Living Inc.	D	46/100	—	26.2%	0.3%	+2.91%	$2.45B	/bkd-vs-md →
SGRY Surgery Partners Inc.	C+	66/100	—	—	9.9%	-0.13%	$3.04B	/sgry-vs-md →
ARDT Ardent Health Inc.	C+	67/100	12.8x	—	10.5%	+3.10%	$1.73B	/ardt-vs-md →
NHC National HealthCare Corporation	C+	69/100	27.7x	—	10.1%	+0.18%	$3.32B	/nhc-vs-md →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000893949

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Pediatrix Medical Group Inc. (MD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $165.4M, operating cash flow of $271.1M, and free cash flow of $271.1M (+31.2% YoY). On the balance sheet, MD closed FY2025 with $2.25B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$165.4M	$271.1M	$271.1M	$2.25B	—
FY2024 (FY)	2024-12-31	$0	-$99.1M	$206.6M	$206.6M	$2.15B	—
FY2023 (FY)	2023-12-31	$0	-$60.4M	$137.3M	$137.3M	—	—

3. MD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Pediatrix Medical Group Inc. (NYSE: MD) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $29.18 (+0.93% 1D, market cap $2.37B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, MD ranks #53 in composite RQD confidence.

How does MD compare to BKD and SGRY in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), MD carries a Roarable B (74/100 RQD), trailing P/E of 14.3x, gross margin of —, and ROIC of 33.6%. By comparison, BKD (Brookdale Senior Living Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC 0.3%, cap $2.45B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MD?

Per MD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000893949), Pediatrix Medical Group Inc. generated $0 in revenue, $165.4M in net income, and $271.1M in free cash flow against $2.25B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MD trading relative to its 50-day, 200-day, and 52-week technical levels?

MD last traded at $29.18 (+0.93% on volume of 832,584 shares), positioning the stock +8.35% above its 50-day simple moving average ($26.93) and +22.25% above its 200-day simple moving average ($23.87). Across its 52-week range of $17.23 to $30.55, MD sits at the 89.7% percentile with a 14-day RSI of 71.7 (OVERBOUGHT (>70)) and an implied next-earnings move of ±6.7% ($27.22 to $31.14).

MD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are MD insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies MD leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

Direct Sub-Reports: MD RQD Cockpit MD 12M Forecast MD Earnings & Move MD Dividends & DRIP MD Insiders & 13F MD Whale Options MD Profit Sankey MD News & Why